CasNo.479633-63-1,4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine479633-63-1,(479633-63-1) Suppliers

1 Kilogram	FOB Price: USD 10.0000

Min.Order :1 Kilogram
Purity: 98%min
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

Tofacitinib intermediate Tofacitinib supplier low price Tofacitinib intermediate

Quick Details

Appearance:solid
Application:Tofacitinib intermediate
PackAge:25kg/package
ProductionCapacity:1000|Kilogram|Month
Storage:Store in dry place. Avoid Moisture.tightly package under room temperature
Transportation:by air

Superiority:

Wuhan Sunrise Technology Development Company limited(Wuhan Sunrise Pharmaceutical Tehcnology Co., Ltd) Wuhan Sunrise Technology Development Company limited is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The main business are R&D, technology transfer and technical services of APIs and pharmaceutical intermediates; R&D, manufacture and sales of PIs. Moreover, we have the right of dealing self-managed imp & exp business.
Main products:
Chemical synthesis series：
anti-cancer pharmaceutical intermediates，
ophthalmology APIs and related intermediates
Biological series: Mabs

Purity: 98%min.W e can offer the quantity from R&D to commercial quantities.We can support with TDP documents for support. The series are our most important pharmaceutical projects

Details:

Purity: 98%min.W e can offer the quantity from R&D to commercial quantities.We can support with TDP documents for support. The series are our most important pharmaceutical projects

Wuhan Sunrise Technology Development Company limited(Wuhan Sunrise Pharmaceutical Tehcnology Co., Ltd) Wuhan Sunrise Technology Development Company limited is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The main business are R&D, technology transfer and technical services of APIs and pharmaceutical intermediates; R&D, manufacture and sales of PIs. Moreover, we have the right of dealing self-managed imp & exp business.
Main products:
Chemical synthesis series：
anti-cancer pharmaceutical intermediates，
ophthalmology APIs and related intermediates
Biological series: Mabs